Revolution Medicines Inc (NASDAQ: RVMD) is 57.91% higher on its value in year-to-date trading and has touched a low of $25.93 and a high of $62.40 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RVMD stock was last observed hovering at around $44.39 in the last trading session, with the day’s gains setting it 0.9%.
Currently trading at $45.29, the stock is -4.11% and -11.86% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.81 million and changing 2.03% at the moment leaves the stock 5.11% off its SMA200. RVMD registered 56.71% gain for a year compared to 6-month gain of 17.54%. The firm has a 50-day simple moving average (SMA 50) of $51.4606 and a 200-day simple moving average (SMA200) of $43.0302.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -21.23% loss in the last 1 month and extending the period to 3 months gives it a 3.26%, and is 5.40% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.13% over the week and 4.23% over the month.
Revolution Medicines Inc (RVMD) has around 378 employees, a market worth around $8.26B and $0.74M in sales. Profit margin for the company is -76423.32%. Distance from 52-week low is 74.66% and -27.42% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.48%).
The EPS is expected to grow by 9.86% this year
365.0 institutions hold shares in Revolution Medicines Inc (RVMD), with institutional investors hold 97.07% of the company’s shares. The shares outstanding are 167.75M, and float is at 151.64M with Short Float at 10.91%. Institutions hold 95.20% of the Float.
The top institutional shareholder in the company is JPMORGAN CHASE & CO with over 3.12 million shares valued at $120.92 million. The investor’s holdings represent 1.8866 of the RVMD Shares outstanding. As of 2024-06-30, the second largest holder is VOYA INVESTMENT MANAGEMENT LLC with 0.26 million shares valued at $10.21 million to account for 0.1593 of the shares outstanding. The other top investors are which holds 27400.0 shares representing 0.0166 and valued at over $1.06 million, while VANGUARD GROUP INC holds 0.0087 of the shares totaling 14.38 million with a market value of $558.02 million.
Revolution Medicines Inc (RVMD) Insider Activity
The most recent transaction is an insider sale by Horn Margaret A, the company’s Chief Operating Officer. SEC filings show that Horn Margaret A sold 4,329 shares of the company’s common stock on Dec 16 ’24 at a price of $45.40 per share for a total of $0.2 million. Following the sale, the insider now owns 0.13 million shares.
Revolution Medicines Inc disclosed in a document filed with the SEC on Dec 16 ’24 that GOLDSMITH MARK A () sold a total of 11,714 shares of the company’s common stock. The trade occurred on Dec 16 ’24 and was made at $45.40 per share for $0.53 million. Following the transaction, the insider now directly holds 0.33 million shares of the RVMD stock.
Still, SEC filings show that on Dec 16 ’24, Kelsey Stephen Michael () disposed off 4,663 shares at an average price of $45.40 for $0.21 million. The insider now directly holds 259,745 shares of Revolution Medicines Inc (RVMD).
